logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Angiotensin Converting Enzyme Inhibitor class drugs

    FiltersReset Filters
    9 results

    • benazepril hydrochloride and hydrochlorothiazide

      (Benazepril Hydrochloride and Hydrochlorothiazide)
      ANI Pharmaceuticals, Inc.
      Usage: Benazepril hydrochloride and hydrochlorothiazide tablets are indicated for the treatment of hypertension. This combination medication is not intended for initial hypertension therapy.

    • benazepril hydrochloride and hydrochlorothiazide

      (benazepril hydrochloride and hydrochlorothiazide)
      Advagen Pharma Ltd
      Usage: Benazepril HCl and Hydrochlorothiazide is indicated for the treatment of hypertension but is not intended for initial therapy of this condition.

    • captopril

      (Captopril)
      Ajanta Pharma USA Inc.
      Usage: Captopril is indicated for treating hypertension, heart failure, left ventricular dysfunction post-myocardial infarction, and diabetic nephropathy in type I diabetes patients. It is effective alone or with other antihypertensives and can improve survival and reduce hospitalizations in specific heart failure patients. Caution is advised in certain populations.

    • captopril

      (captopril)
      Method Pharmaceuticals LLC
      Usage: Captopril is indicated for treating hypertension, congestive heart failure, improving survival in post-myocardial infarction patients with left ventricular dysfunction, and diabetic nephropathy in type 1 diabetes. It is effective alone or with diuretics and required careful consideration of risks in patients with renal impairment or specific demographics.

    • enalapril maleate

      (Enalapril maleate)
      Wilshire Pharmaceuticals, Inc.
      Usage: Enalapril maleate is indicated for treating hypertension in adults and children over one month, reducing cardiovascular risks. It also treats symptomatic heart failure, enhancing survival and reducing hospitalizations. Additionally, it benefits asymptomatic patients with left ventricular dysfunction by decreasing heart failure development and related hospitalizations.

    • enalapril maleate

      (Enalapril maleate)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Enalapril maleate tablets are indicated for treating hypertension, symptomatic congestive heart failure, and asymptomatic left ventricular dysfunction. They can be used alone or with other antihypertensives, improving symptoms and reducing hospitalization in heart failure patients. Caution is advised in patients with specific health conditions and demographics.

    • epaned

      (enalapril maleate)
      Azurity Pharmaceuticals, Inc.
      Usage: EPANED is indicated for treating hypertension in adults and children over one month, improving cardiovascular outcomes. It is also indicated for symptomatic heart failure, often with diuretics and digitalis, enhancing survival and reducing hospitalizations, and for asymptomatic left ventricular dysfunction, decreasing progression to overt heart failure.

    • ramipril

      (Ramipril)
      Rising Pharma Holdings, Inc.
      Usage: Ramipril capsules are indicated for treating hypertension, reducing cardiovascular event risks (myocardial infarction, stroke, death) in high-risk patients aged 55 or older, and managing heart failure following myocardial infarction. They may be used alone or in combination with other therapies to achieve desired outcomes.

    • ramipril

      (Ramipril)
      Chartwell RX, LLC.
      Usage: Ramipril capsules are indicated for treating hypertension to lower blood pressure, reducing cardiovascular event risks. They are also used in stable patients with heart failure post-myocardial infarction to decrease death risk and hospitalizations. This medication can be used alone or with thiazide diuretics.